nabumetone
Generic: nabumetone
Labeler: lupin pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
nabumetone
Generic Name
nabumetone
Labeler
lupin pharmaceuticals, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
nabumetone 750 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68180-142
Product ID
68180-142_54834b73-96d1-4f73-953d-a3407be454d6
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090445
Listing Expiration
2026-12-31
Marketing Start
2011-01-12
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
68180142
Hyphenated Format
68180-142
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
nabumetone (source: ndc)
Generic Name
nabumetone (source: ndc)
Application Number
ANDA090445 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 750 mg/1
Packaging
- HOW SUPPLIED Nabumetone Tablets USP, 500 mg are available as white to off white, oval shaped, biconvex, film-coated tablets, debossed with "LU" on one side and "V01" on the other side. They are supplied as follows: NDC 68180-141-01 Bottles of 100's NDC 68180-141-03 Bottles of 1000's Nabumetone Tablets USP, 750 mg are available as white to off white, oval shaped, biconvex, film-coated tablets, debossed with "LU" on one side and "V02" on the other side. They are supplied as follows: NDC 68180-142-01 Bottles of 100's NDC 68180-142-03 Bottles of 1000's Store at 25°C (77°F); excursions permitted to 15°-30°C (59°- 86°F) [see USP Controlled Room Temperature]. Preserve in well-closed containers. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). _____________________________________________________________________________________________________ 1 Throughout this package insert, the term NSAID refers to a non-aspirin non- steroidal anti-inflammatory drug. 2 Incidence of reported reaction between 3% and 9%. Reactions occurring in 1% to 3% of the patients are unmarked. 3 † Adverse reactions reported only in worldwide postmarketing experience or in the literature, not seen in clinical trials, are considered rarer and are italicized. Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States Manufactured by: Lupin Limited Goa 403722 INDIA August 7, 2015 ID#: 242328
- PRINCIPAL DISPLAY PANEL NDC 68180-141-01 NABUMETONE TABLETS USP 500 MG Rx only Bottle of 100 Tablets NDC 68180-142-01 NABUMETONE TABLETS USP 750 MG Rx only Bottle of 100 Tablets 500 MG 100 count 750 MG 100s count
Packages (0)
No package records.
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "54834b73-96d1-4f73-953d-a3407be454d6", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0368180142010", "0368180141013"], "unii": ["LW0TIW155Z"], "rxcui": ["311892", "311893"], "spl_set_id": ["cf96d189-5417-4181-a5fb-169b269560a2"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Nabumetone", "product_id": "68180-142_54834b73-96d1-4f73-953d-a3407be454d6", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "68180-142", "generic_name": "nabumetone", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nabumetone", "active_ingredients": [{"name": "NABUMETONE", "strength": "750 mg/1"}], "application_number": "ANDA090445", "marketing_category": "ANDA", "marketing_start_date": "20110112", "listing_expiration_date": "20261231"}